Ryman Healthcare Ltd
NZX:RYM

Watchlist Manager
Ryman Healthcare Ltd Logo
Ryman Healthcare Ltd
NZX:RYM
Watchlist
Price: 4.64 NZD 3.11% Market Closed
Market Cap: 3.2B NZD
Have any thoughts about
Ryman Healthcare Ltd?
Write Note
Section:
 

Relative Value

The Relative Value of one RYM stock under the Base Case scenario is 13.74 NZD. Compared to the current market price of 4.64 NZD, Ryman Healthcare Ltd is Undervalued by 66%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RYM Relative Value
Base Case
13.74 NZD
Undervaluation 66%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

4.6
P/S
P/S
Price to Sales
4.6
vs History
87
vs Industry
29
Median 3Y
7
Median 5Y
10.8
Industry
2.3
Forward
3.3
More Details
668.2
P/E
P/E
Price to Earnings
668.2
vs History
1
vs Industry
0
Median 3Y
15.7
Median 5Y
18.7
Industry
23.2
Forward
12.6
More Details
4.8
P/OCF
P/OCF
Price to OCF
4.8
vs History
84
vs Industry
47
Median 3Y
6.9
Median 5Y
8.7
Industry
14.3
More Details
4.7
P/FCFE
P/FCFE
Price to FCFE
4.7
vs History
84
vs Industry
38
Median 3Y
7.4
Median 5Y
9.3
Industry
20.1
More Details
0.7
P/B
P/B
Price to Book Value
0.7
vs History
84
vs Industry
72
Median 3Y
1
Median 5Y
1.4
Industry
2.2
More Details
8.3
EV/S
EV/S
Enterprise Value to Sales
8.3
vs History
87
vs Industry
15
Median 3Y
12.4
Median 5Y
15.4
Industry
2.4
Forward
6
More Details
N/A
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
5
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
0
Median 3Y
-175.8
Median 5Y
174.1
Industry
12.8
Forward
16.8
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
0
Median 3Y
-175.8
Median 5Y
174.1
Industry
17.2
Forward
19.5
More Details
8.7
EV/OCF
EV/OCF
Enterprise Value to OCF
8.7
vs History
79
vs Industry
39
Median 3Y
11.7
Median 5Y
13.5
Industry
14
More Details
11.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
11.8
vs History
85
vs Industry
32
Median 3Y
22.7
Median 5Y
27
Industry
18.2
More Details
0.4
EV/IC
EV/IC
Enterprise Value to IC
0.4
vs History
85
vs Industry
78
Median 3Y
0.6
Median 5Y
0.7
Industry
1.9
More Details

Multiples Across Competitors

RYM Competitors Multiples
Ryman Healthcare Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
NZ
Ryman Healthcare Ltd
NZX:RYM
3.2B NZD 4.6 668.2 -189 -189
US
HCA Healthcare Inc
NYSE:HCA
78.1B USD 1.1 13.2 8.3 10.8
SA
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
98B SAR 9.3 44 39 45.3
ZA
Life Healthcare Group Holdings Ltd
JSE:LHC
23.8B Zac 0 0 0 0
ZA
Netcare Ltd
JSE:NTC
19.8B Zac 0 0 0 0
CN
Aier Eye Hospital Group Co Ltd
SZSE:300015
128.4B CNY 6.2 35.4 26.7 26.7
MY
IHH Healthcare Bhd
KLSE:IHH
63.7B MYR 2.7 24 13 18.7
IN
Max Healthcare Institute Ltd
NSE:MAXHEALTH
1.1T INR 19.3 103.9 72.1 85.9
IN
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
1T INR 5.3 100.5 41.9 57.3
US
Tenet Healthcare Corp
NYSE:THC
12.2B USD 0.6 3.9 5.2 6.5
US
Universal Health Services Inc
NYSE:UHS
11.9B USD 0.8 11.6 7.7 10.7

See Also

Summary
RYM intrinsic value, competitors valuation, and company profile.
DCF Valuation
RYM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RYM stock valuation using valuation multiples.
Wall Street Estimates
RYM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RYM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.